• Eidos Therapeutics Special Committee Rejects Proposal from BridgeBio Pharma to Acquire Shares

    I refer to your non-binding proposal dated August 8, 2019 (the “Proposal”), proposing to acquire all of the outstanding shares of common stock of Eidos …

    Read More
  • 0 0